Development of Selective, Allosteric Inhibitors of Cyclin-Dependent Kinase 2 for theTherapeutic Treatment of Cancer
|Effective start/end date||9/1/23 → 8/31/24|
- AMERICAN FDN FOR PHARMACEUTICAL EDUC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.